Platelet activating factor increases expression of complement receptors on human neutrophils

Area of Science:

• Immunology
• Cell Biology
• Inflammation Research

Background:

• Platelet activating factor (PAF) is a key inflammatory mediator known to activate polymorphonuclear leukocytes (PMN).
• The impact of PAF on the surface expression of complement receptors on PMN remained largely undescribed.
• Understanding these interactions is crucial for comprehending inflammatory processes.

Purpose of the Study:

• To investigate the effect of PAF on the surface expression of complement receptors CR3 and CR1 in human PMN.
• To quantify the changes in receptor expression induced by PAF and compare them to other inflammatory mediators.
• To explore the role of calcium and PAF antagonists in these PAF-mediated effects.

Main Methods:

• Human PMN were treated with PAF and its analogue lyso-PAF.
• Surface expression of CR3 and CR1 was measured using monoclonal antibodies and flow cytometry.
• PAF receptor antagonist SRI 63-441 was used to assess receptor blockade.
• The influence of extracellular calcium and combined stimulation with LTB4 was evaluated.

Main Results:

• PAF significantly increased CR3 expression by 190% and CR1 expression by 174% in human PMN.
• These increases were dose-dependent, reaching maximum levels within 15-30 minutes.
• A PAF receptor antagonist blocked these effects, while extracellular calcium had a minor role.
• Combined PAF and LTB4 stimulation showed additive effects on receptor expression.

Conclusions:

• PAF induces a significant upregulation of complement receptors CR3 and CR1 on PMN surface.
• This PAF-mediated modulation of complement receptors may play a vital role in enhancing PMN adhesion and phagocytosis during inflammation.
• These findings provide new insights into the mechanisms of PMN activation and inflammatory response.